rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
5	Obesity	C0028754	5	2181	0.0	6.112469437652812e-06	JAK2,GHR,GH2,PTPN1,GH1
7	Diabetes mellitus type 2	C0011860	5	1972	0.0	8.557457212713935e-06	JAK2,GHR,GH2,PTPN1,GH1
10	Growth Disorders	C0018273	3	81	5.06166220049e-10	1.2224938875305624e-05	JAK2,GHR,GH1
12	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	C0271561	3	91	7.93427878953e-10	1.4669926650366748e-05	GHR,PTPN1,GH1
16	Liver Diseases	C0023895	4	586	6.20932405493e-09	1.9559902200488996e-05	JAK2,GHR,PTPN1,GH1
17	Diabetic Nephropathies	C0011881	4	616	8.00734700768e-09	2.078239608801956e-05	JAK2,GHR,PTPN1,GH1
18	46,XY gonadal dysgenesis, partial, with minifascicular neuropathy	C0041408	3	164	8.1564833776e-09	2.2004889975550122e-05	GHR,PTPN1,GH1
19	Metabolic Syndrome X	C0524620	4	638	9.51256051707e-09	2.3227383863080685e-05	GHR,GH2,PTPN1,GH1
20	Craniometaphyseal dysplasia, autosomal dominant	C1852502	2	27	1.05018859164e-08	2.4449877750611248e-05	JAK2,GHR
21	Isolated somatotropin deficiency	C3714796	2	30	1.45104135374e-08	2.567237163814181e-05	GHR,GH1
22	Fibrous Dysplasia	C0259779	2	31	1.61029574119e-08	2.689486552567237e-05	GHR,GH1
23	Isolated growth hormone deficiency type 1B	C0013338	2	32	1.7751979553e-08	2.8117359413202937e-05	GHR,GH1
24	Generalized osteoarthritis	C0409952	2	33	1.95461843377e-08	2.9339853300733496e-05	GHR,GH1
25	X-linked severe combined immunodeficiency	C1279481	2	35	2.34684821576e-08	3.0562347188264056e-05	GHR,GH1
35	Panhypopituitarism X-linked	C0242343	2	45	5.0657691264e-08	4.2787286063569685e-05	GHR,GH1
36	Somatotroph adenoma	C0346302	2	45	5.0657691264e-08	4.4009779951100244e-05	GHR,GH1
37	Pediatric Obesity	C2362324	2	46	5.42106218804e-08	4.523227383863081e-05	GHR,GH1
49	Glucose intolerance	C0271650	3	304	9.66069545472e-08	5.990220048899755e-05	GHR,PTPN1,GH1
50	Russell-Silver syndrome	C0175693	2	56	9.88300564719e-08	6.112469437652811e-05	GH2,GH1
51	Pituitary Neoplasms	C0032019	3	321	1.20157888972e-07	6.234718826405868e-05	GHR,GH2,GH1
52	Congenital hypothyroidism	C0010308	2	60	1.22029440885e-07	6.356968215158924e-05	GHR,GH1
53	Esophagitis	C0014868	2	62	1.34812827568e-07	6.47921760391198e-05	GH2,GH1
54	Insulin Resistance	C0021655	3	332	1.37484366114e-07	6.601466992665036e-05	JAK2,PTPN1,GH1
55	Diabetes mellitus type 1	C0011854	4	1104	1.47850428345e-07	6.723716381418094e-05	JAK2,GHR,PTPN1,GH1
56	Proportionate short stature	C0205351	2	65	1.55648114175e-07	6.845965770171148e-05	GHR,GH1
57	Noonan syndrome 1	C0028326	2	66	1.63064621694e-07	6.968215158924206e-05	PTPN1,GH1
58	Hyperinsulinemia	C0020459	3	355	1.79809651724e-07	7.090464547677261e-05	JAK2,PTPN1,GH1
67	Acromegaly	C0001206	2	70	1.95017740623e-07	8.190709046454768e-05	GHR,GH1
68	Metaplasia	C0025568	2	80	2.92500034971e-07	8.312958435207824e-05	GH2,GH1
69	Polycythemia	C0032461	2	81	3.03706618188e-07	8.435207823960881e-05	JAK2,GH1
81	Hodgkin Disease	C0019829	3	409	3.16931266564e-07	9.902200488997555e-05	JAK2,PTPN1,GH1
97	Prader-Willi syndrome	C0032897	2	109	7.46007814412e-07	0.00011858190709046456	GHR,GH1
103	Malnutrition	C0162429	2	122	1.04833009673e-06	0.00012591687041564793	GHR,GH1
104	Non-Hodgkin lymphoma	C0024305	3	556	1.08140347188e-06	0.0001271393643031785	GHR,PTPN1,GH1
105	Hypertension	C0020538	4	1647	1.09541287352e-06	0.00012836185819070905	JAK2,GHR,PTPN1,GH1
109	Alzheimer Disease	C0002395	4	1699	1.27980035358e-06	0.0001332518337408313	JAK2,GHR,PTPN1,GH1
110	Obesity, severe, 601665 (3)	C0028756	2	131	1.29937096505e-06	0.00013447432762836187	PTPN1,GH1
117	Abdominal obesity	C0311277	2	134	1.39117359088e-06	0.0001430317848410758	GHR,GH1
118	Mammary Tumorigenesis	C1512981	2	141	1.62194494879e-06	0.00014425427872860635	JAK2,GH1
123	Hypohidrosis	C0020620	2	150	1.95425515559e-06	0.00015036674816625917	JAK2,GHR
124	Abnormality of the pituitary gland	C0032002	3	645	1.95580043572e-06	0.00015158924205378973	GHR,GH2,GH1
130	Malignant tumor of esophagus	C0546837	3	650	2.01697877045e-06	0.00015892420537897312	JAK2,GH2,GH1
131	Neurofibromatosis, type 1, 162200 (3)	C0027831	2	152	2.03381209429e-06	0.00016014669926650365	JAK2,GH1
138	Esophageal Neoplasms	C0014859	3	686	2.50062638463e-06	0.00016870415647921762	JAK2,GH2,GH1
139	Abnormality of blood glucose concentration	C4023597	2	166	2.65138700262e-06	0.00016992665036674818	GHR,GH1
140	Tumor Progression	C0178874	4	1969	2.67760069628e-06	0.00017114914425427874	JAK2,GHR,PTPN1,GH1
147	Amyotrophy involving the shoulder musculature	C0026846	2	179	3.32616374787e-06	0.00017970660146699266	GHR,GH1
154	Gallbladder disease 4	C0012634	3	785	4.27893790877e-06	0.0001882640586797066	JAK2,GHR,GH1
155	Ovarian epithelial cancer	C0677886	4	2172	4.37539403486e-06	0.0001894865525672372	JAK2,GHR,PTPN1,GH1
161	Maternal diabetes	C0085207	2	210	5.37439765647e-06	0.00019682151589242054	GH2,GH1
163	Blast Phase	C0005699	2	221	6.26437463658e-06	0.00019926650366748166	JAK2,PTPN1
164	Testicular seminoma	C0036631	2	222	6.34983102776e-06	0.00020048899755501225	GH2,GH1
168	Liver failure acute infantile	C0085605	2	223	6.43598088412e-06	0.0002053789731051345	JAK2,PTPN1
169	Animal Mammary Neoplasms	C0024667	4	2352	6.51716944999e-06	0.00020660146699266505	JAK2,GHR,PTPN1,GH1
170	Malabsorption	C0024523	2	224	6.52299162207e-06	0.0002078239608801956	JAK2,GH1
171	Esophageal Squamous Cell Carcinoma	C0279626	3	888	6.98970571833e-06	0.00020904645476772617	JAK2,GHR,PTPN1
173	Delayed skeletal maturation	C0541764	2	234	7.43610091991e-06	0.00021149144254278729	GHR,GH1
177	Liver Cirrhosis, Biliary	C0023890	3	919	8.01191435129e-06	0.00021638141809290955	JAK2,GHR,GH1
183	Osteosarcoma	C0585442	3	936	8.61762367765e-06	0.0002237163814180929	JAK2,GHR,GH1
184	Germ cell neoplasia	C0205851	2	252	9.28618518314e-06	0.0002249388753056235	GH2,GH1
185	Colorectal cancer 1	C0009402	4	2543	9.6325469503e-06	0.00022616136919315403	JAK2,GHR,PTPN1,GH1
186	Thrombophilia due to activated protein C resistance	C1861171	1	26	9.89780577021e-06	0.00022738386308068459	JAK2
187	Granulocytic Sarcoma	C0152276	1	26	9.89780577021e-06	0.00022860635696821517	JAK2
188	Hypereosinophilic syndrome	C1540912	1	26	9.89780577021e-06	0.00022982885085574573	JAK2
189	Adenomas, multiple colorectal, 608456 (3)	C0001430	3	975	1.01360708059e-05	0.0002310513447432763	GHR,GH2,GH1
190	Abnormality of circulating hormone level	C4025652	2	262	1.04347002701e-05	0.00023227383863080685	GHR,GH1
191	Cardiovascular morbidity	C1301700	1	27	1.06887349076e-05	0.0002334963325183374	GH1
192	Esophageal varix	C0014867	1	27	1.06887349076e-05	0.00023471882640586797	JAK2
193	Gallbladder adenocarcinoma	C0279651	1	27	1.06887349076e-05	0.00023594132029339853	JAK2
194	Bulimia	C0006370	1	27	1.06887349076e-05	0.00023716381418092912	GHR
195	Hypoglycemia, neonatal, simulating foetopathia diabetica	C0020615	2	265	1.07968057167e-05	0.00023838630806845965	GHR,GH1
196	Abnormality of skeletal maturation	C4025818	2	268	1.1167122092e-05	0.0002396088019559902	GHR,GH1
197	Diabetic Retinopathy	C0011884	2	270	1.14185923547e-05	0.0002408312958435208	PTPN1,GH1
198	Idiopathic hypereosinophilic syndrome	C0206141	1	28	1.15100573882e-05	0.00024205378973105135	JAK2
199	Thrombosis of retinal vein	C0035328	1	28	1.15100573882e-05	0.00024327628361858191	JAK2
200	Familial X-linked hypophosphatemic vitamin D refractory rickets	C3536984	1	28	1.15100573882e-05	0.00024449877750611245	GH1
201	Adrenal Gland Hyperfunction	C0001622	1	28	1.15100573882e-05	0.00024572127139364303	GH1
202	Pseudohypoparathyroidism, Type Ia	C3494506	1	28	1.15100573882e-05	0.0002469437652811736	GH1
203	Achondroplasia	C0001080	1	28	1.15100573882e-05	0.00024816625916870415	GH1
204	Smith-Magenis syndrome	C0795864	1	28	1.15100573882e-05	0.00024938875305623474	GH1
205	Septo-optic dysplasia sequence	C0338503	1	28	1.15100573882e-05	0.0002506112469437653	GH1
206	High pitched voice	C0241703	1	28	1.15100573882e-05	0.00025183374083129586	GHR
207	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	C1292772	1	29	1.23616784783e-05	0.0002530562347188264	JAK2
208	Chromosomal translocation	C0040715	1	29	1.23616784783e-05	0.000254278728606357	JAK2
209	Pituitary dependent hypercortisolism	C0221406	1	29	1.23616784783e-05	0.0002555012224938875	GHR
210	Colorectal cancer	C1527249	4	2681	1.25481947898e-05	0.0002567237163814181	JAK2,GHR,PTPN1,GH1
211	Choriocarcinoma	C0008497	2	279	1.2596777164e-05	0.00025794621026894863	JAK2,GH2
212	Pseudohypoparathyroidism type 1A	C0033806	1	30	1.32435615282e-05	0.0002591687041564792	GH1
213	Tinnitus	C0040264	1	30	1.32435615282e-05	0.0002603911980440098	JAK2
214	Pituitary adenoma	C0032000	2	286	1.35668243633e-05	0.00026161369193154033	GHR,GH1
215	Prostate carcinoma	C0600139	4	2734	1.3839502142e-05	0.0002628361858190709	JAK2,GHR,PTPN1,GH1
216	Arteriosclerosis	C0003850	3	1059	1.40757064482e-05	0.00026405867970660145	JAK2,PTPN1,GH1
217	Intermittent claudication	C0021775	1	31	1.41558434797e-05	0.000265281173594132	JAK2
218	Gingival bleeding	C0017565	1	31	1.41558434797e-05	0.0002665036674816626	JAK2
219	Central hypothyroidism	C0271801	1	31	1.41558434797e-05	0.00026772616136919316	GH1
220	Monocytosis	C0085702	1	31	1.41558434797e-05	0.00026894865525672375	JAK2
221	Creutzfeldt-Jakob Disease, Sporadic	C1852467	1	31	1.41558434797e-05	0.0002701711491442543	GH1
222	Chronic leukemia	C1279296	1	31	1.41558434797e-05	0.0002713936430317848	JAK2
223	Philadelphia chromosome positive	C0856536	1	32	1.50983724673e-05	0.0002726161369193154	JAK2
224	Carney complex	C0406810	1	33	1.60712265181e-05	0.00027383863080684593	GH1
225	Exertional dyspnea	C0231807	1	34	1.70743120199e-05	0.00027506112469437657	JAK2
226	Cushing's syndrome	C0010481	1	34	1.70743120199e-05	0.0002762836185819071	GH1
227	Hypervolemia	C0546817	1	34	1.70743120199e-05	0.00027750611246943764	GH1
228	Erythrocytosis	C1527405	1	34	1.70743120199e-05	0.0002787286063569682	JAK2
229	Chronic eosinophilic leukemia	C0346421	1	35	1.81077654574e-05	0.00027995110024449875	JAK2
230	Myelosuppression	C0854467	1	35	1.81077654574e-05	0.00028117359413202934	JAK2
231	Resistance to activated protein C	C0600433	1	35	1.81077654574e-05	0.00028239608801955993	JAK2
232	Acquired scoliosis	C0700208	1	35	1.81077654574e-05	0.00028361858190709046	GH1
233	Ileitis	C0020877	1	35	1.81077654574e-05	0.00028484107579462105	GH1
234	Leiomyoma	C0023267	2	316	1.82855300556e-05	0.0002860635696821516	GHR,GH1
235	Non-alcoholic Fatty Liver Disease	C0400966	2	317	1.84591166968e-05	0.00028728606356968217	JAK2,PTPN1
236	Recurrent tumor	C0521158	2	320	1.89865216517e-05	0.0002885085574572127	JAK2,GH1
237	Complete trisomy 18 syndrome	C0152096	1	36	1.91713478532e-05	0.00028973105134474323	GH1
238	Prolonged bleeding time	C0439590	1	36	1.91713478532e-05	0.00029095354523227387	JAK2
239	Malignant tumor of prostate	C0376358	4	2940	1.99056273483e-05	0.0002921760391198044	JAK2,GHR,PTPN1,GH1
240	Serositis	C0036749	1	37	2.02653116123e-05	0.000293398533007335	JAK2
241	Abnormal delivery	C0549629	1	37	2.02653116123e-05	0.0002946210268948655	JAK2
242	Mesenchymal Cell Neoplasm	C1334699	1	37	2.02653116123e-05	0.00029584352078239606	JAK2
243	Genomic Instability	C0919532	1	37	2.02653116123e-05	0.00029706601466992664	JAK2
244	Peripheral artery occlusive disease	C1306889	1	37	2.02653116123e-05	0.00029828850855745723	JAK2
245	Mediastinal (Thymic) Large B-Cell Lymphoma	C1292754	1	37	2.02653116123e-05	0.0002995110024449878	JAK2
246	Uterine leiomyoma	C0042133	2	331	2.10055173491e-05	0.00030073349633251835	GHR,GH1
247	Chromosome 5, trisomy 5q	C1802398	1	38	2.13894756095e-05	0.0003019559902200489	JAK2
248	Pregnancy in Diabetics	C0032969	1	38	2.13894756095e-05	0.00030317848410757947	GH2
249	End Stage Liver Disease	C0745744	1	38	2.13894756095e-05	0.00030440097799511	GHR
250	Breast hypoplasia	C0266013	1	39	2.25438903597e-05	0.00030562347188264064	GH1
251	Pancreatitis, Acute Necrotizing	C0267941	1	39	2.25438903597e-05	0.00030684596577017117	GH1
252	Gastro-esophageal reflux disease with esophagitis	C0677659	1	39	2.25438903597e-05	0.0003080684596577017	GHR
253	Keratoconjunctivitis	C0022573	1	40	2.37285470422e-05	0.0003092909535452323	GH1
254	Amaurosis fugax	C0149793	1	40	2.37285470422e-05	0.0003105134474327628	JAK2
255	Arterial Occlusive Diseases	C0003838	1	41	2.49434397357e-05	0.0003117359413202934	JAK2
256	Stroke	C0038454	3	1229	2.54122132097e-05	0.00031295843520782394	JAK2,GHR,GH1
257	Camptomelic dysplasia	C1861922	1	42	2.61885298005e-05	0.00031418092909535453	JAK2
258	Hepatocellular carcinoma	C2239176	4	3108	2.62859459955e-05	0.0003154034229828851	JAK2,GHR,PTPN1,GH1
259	Hyperlipoproteinemia Type IIa	C0745103	1	43	2.74638972592e-05	0.00031662591687041565	GHR
260	Hyperlipoproteinemia	C0020476	1	43	2.74638972592e-05	0.00031784841075794623	GHR
261	Deep thrombophlebitis	C0151950	1	44	2.87694774095e-05	0.00031907090464547677	JAK2
262	Abnormality of the hepatic vasculature	C4024994	1	44	2.87694774095e-05	0.0003202933985330073	JAK2
263	Congenital scoliosis	C0559260	1	44	2.87694774095e-05	0.00032151589242053794	GH1
264	Atherosclerosis	C0004153	3	1271	2.90331404733e-05	0.0003227383863080685	JAK2,PTPN1,GH1
265	Adolescent idiopathic scoliosis	C0410702	1	45	3.01052031225e-05	0.00032396088019559906	GHR
266	Mammary Carcinoma, Human	C1257930	1	45	3.01052031225e-05	0.0003251833740831296	GH1
267	Neoplasm of the liver	C0023903	3	1290	3.0791570778e-05	0.0003264058679706601	GHR,PTPN1,GH1
268	Heart valve disease	C0018824	1	46	3.14711835935e-05	0.0003276283618581907	JAK2
269	Underdeveloped supraorbital ridges	C1861869	1	46	3.14711835935e-05	0.00032885085574572124	GHR
270	Osteogenesis imperfecta	C0029434	1	46	3.14711835935e-05	0.0003300733496332519	GH1
271	Isochromosomes	C0242621	1	47	3.28673812214e-05	0.0003312958435207824	JAK2
272	Heart Diseases	C0018799	2	386	3.32476558733e-05	0.00033251833740831295	JAK2,GHR
273	Hypokalemia	C0020621	1	48	3.42936443659e-05	0.00033374083129584354	GH1
274	Cytogenetically normal acute myeloid leukemia	C3839868	1	48	3.42936443659e-05	0.00033496332518337407	JAK2
275	Disorders of Intracellular Cobalamin Metabolism	C0025517	2	394	3.53468186745e-05	0.00033618581907090465	PTPN1,GH1
276	Rous Sarcoma	C0086942	1	49	3.57501671625e-05	0.00033740831295843524	GH1
277	Hemophilia, NOS	C0684275	1	49	3.57501671625e-05	0.0003386308068459658	GH1
278	Sideroblastic anemia 3, pyridoxine-refractory	C0002896	1	49	3.57501671625e-05	0.00033985330073349636	JAK2
279	Osteopetrosis autosomal recessive 4	C0029454	1	49	3.57501671625e-05	0.0003410757946210269	GHR
280	Exostoses	C0015302	1	49	3.57501671625e-05	0.0003422982885085575	GH1
281	Iron deficiency anemia	C0162316	1	50	3.72367983047e-05	0.000343520782396088	JAK2
282	Lymphoma, Large B-Cell, Diffuse	C0024299	3	1362	3.8182895745e-05	0.00034474327628361854	JAK2,GH2,PTPN1
283	Peptic Esophagitis	C0014869	1	52	4.03006125627e-05	0.0003459657701711492	GHR
284	Primary hyperparathyroidism	C0221002	1	53	4.18778378245e-05	0.0003471882640586797	JAK2
285	Benign Prostatic Hyperplasia	C1704272	2	423	4.36882269509e-05	0.0003484107579462103	JAK2,GH1
286	Secondary hypertriglyceridemia	C0027627	4	3444	4.39308903972e-05	0.00034963325183374084	JAK2,GHR,PTPN1,GH1
287	Refractory anemia	C0002893	1	55	4.51225131011e-05	0.00035085574572127137	JAK2
288	Abnormality of skeletal physiology	C4023164	2	436	4.78145616553e-05	0.00035207823960880196	GHR,GH1
289	Abnormal glucose homeostasis	C4023598	2	436	4.78145616553e-05	0.00035330073349633254	GHR,GH1
290	C-like syndrome	C0039082	2	438	4.84713311477e-05	0.00035452322738386313	JAK2,GHR
291	Hutchinson-Gilford syndrome	C0033300	1	57	4.84877230463e-05	0.00035574572127139366	GH1
292	Female pseudohermaphroditism	C0238394	1	57	4.84877230463e-05	0.0003569682151589242	JAK2
293	Leishmaniasis	C0023281	1	57	4.84877230463e-05	0.0003581907090464548	PTPN1
294	Chronic neutrophilia	C3665444	1	57	4.84877230463e-05	0.0003594132029339853	JAK2
295	Mastocytosis	C0024899	1	57	4.84877230463e-05	0.0003606356968215159	JAK2
296	Dysmorphic features	C0432072	1	57	4.84877230463e-05	0.0003618581907090465	GH1
297	Tumor Angiogenesis	C1519670	2	443	5.01393487116e-05	0.000363080684596577	JAK2,GH1
298	Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease	C0221013	1	58	5.02154584282e-05	0.0003643031784841076	JAK2
299	Abnormal pulmonary vein morphology	C0241665	1	58	5.02154584282e-05	0.00036552567237163814	JAK2
300	Blue sclerae	C0542514	1	58	5.02154584282e-05	0.0003667481662591687	GHR
301	Abnormality of cholesterol metabolism	C4025656	1	59	5.19733778452e-05	0.00036797066014669926	GHR
302	Chromosome 8, trisomy	C0008671	1	59	5.19733778452e-05	0.00036919315403422984	JAK2
303	Meningioma	C0025286	2	452	5.32365415148e-05	0.00037041564792176043	JAK2,GHR
304	Gastrointestinal obstruction	C0236124	1	60	5.37613562001e-05	0.00037163814180929096	JAK2
305	X-linked agammaglobulinemia	C0221026	1	60	5.37613562001e-05	0.00037286063569682155	GH1
306	Supraventricular tachycardia	C0039240	1	60	5.37613562001e-05	0.0003740831295843521	JAK2
307	Hormone receptor positive tumor	C1446409	1	61	5.55794443178e-05	0.0003753056234718826	JAK2
308	Cooley's anemia	C0002875	1	61	5.55794443178e-05	0.0003765281173594132	GH1
309	Colonic Polyps	C0009376	1	61	5.55794443178e-05	0.0003777506112469438	GH1
310	Leukocytosis	C0023518	1	61	5.55794443178e-05	0.0003789731051344744	JAK2
311	Hydatidiform mole, recurrent, 1, 231090 (3)	C3463897	1	62	5.74275482331e-05	0.0003801955990220049	GH1
312	Syncope	C0039070	1	62	5.74275482331e-05	0.00038141809290953544	JAK2
313	Epistaxis	C0014591	1	62	5.74275482331e-05	0.000382640586797066	JAK2
314	secondary acute myeloid leukemia	C0280449	1	63	5.93057742183e-05	0.00038386308068459656	JAK2
315	Down Syndrome	C0013080	2	476	6.21072849576e-05	0.0003850855745721272	JAK2,GH1
316	Ascites	C0003962	1	65	6.31524227536e-05	0.00038630806845965773	JAK2
317	Abnormality of the gallbladder	C0266249	1	65	6.31524227536e-05	0.00038753056234718826	JAK2
318	Carcinogenesis	C0596263	4	3723	6.48655479869e-05	0.00038875305623471885	JAK2,GHR,PTPN1,GH1
319	Hypoxia-Ischemia, Brain	C0752308	1	66	6.51208568508e-05	0.0003899755501222494	GHR
320	Acute myocardial ischemia	C0151744	2	484	6.52675190256e-05	0.00039119804400977997	JAK2,GHR
321	Abnormality of carbohydrate metabolism/homeostasis	C4023599	2	491	6.81182550902e-05	0.0003924205378973105	GHR,GH1
322	Growth abnormality	C0262361	3	1578	6.83561980119e-05	0.0003936430317848411	JAK2,GHR,GH1
323	Disorder of endocrine system	C0014130	1	68	6.91478233414e-05	0.0003948655256723717	GH1
324	 Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	C0206081	1	68	6.91478233414e-05	0.0003960880195599022	GH1
325	Microalbuminuria	C0730345	1	68	6.91478233414e-05	0.0003973105134474328	GH1
326	Pulmonic stenosis	C0034089	1	68	6.91478233414e-05	0.0003985330073349633	PTPN1
327	Abnormality of the sclera	C4025840	1	69	7.12063675745e-05	0.00039975550122249386	GHR
328	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	C0740394	1	69	7.12063675745e-05	0.0004009779951100245	JAK2
329	Sleep apnea	C0037315	1	69	7.12063675745e-05	0.00040220048899755503	GH1
330	Increased body weight	C0043094	2	502	7.27620216339e-05	0.0004034229828850856	GHR,GH1
331	Prostatic Neoplasms	C0033578	3	1606	7.32759090947e-05	0.00040464547677261615	JAK2,GHR,PTPN1
332	Chest pain	C0008031	1	70	7.3294953046e-05	0.0004058679706601467	JAK2
333	Mammographic breast density	C1268717	1	70	7.3294953046e-05	0.00040709046454767727	GH1
334	Abnormality of metabolism/homeostasis	C4021768	3	1607	7.3456306497e-05	0.0004083129584352078	JAK2,GHR,GH1
335	 {HIV-1 viremia, susceptibility to}, 609423 (3)	C0042749	1	71	7.54135701377e-05	0.00040953545232273844	JAK2
336	Well Differentiated Pancreatic Endocrine Tumor	C1337011	1	71	7.54135701377e-05	0.000410757946210269	GH1
337	Somatic mutation	C0544886	1	72	7.75621278024e-05	0.0004119804400977995	JAK2
338	Ischemic cardiomyopathy	C0349782	1	73	7.97407586498e-05	0.0004132029339853301	GH1
339	Angina pectoris	C0002962	1	73	7.97407586498e-05	0.0004144254278728606	JAK2
340	Vertigo	C0042571	1	73	7.97407586498e-05	0.0004156479217603912	JAK2
341	Homocysteinemia due to MTHFR deficiency	C3495426	1	74	8.19493709058e-05	0.0004168704156479218	JAK2
342	Pathologic Neovascularization	C0027686	1	74	8.19493709058e-05	0.00041809290953545233	JAK2
343	Neoplasm of the adrenal cortex	C0001618	1	74	8.19493709058e-05	0.0004193154034229829	GHR
344	Abnormality of the supraorbital ridges	C4022027	1	74	8.19493709058e-05	0.00042053789731051345	GHR
345	Bleeding with minor or no trauma	C0019080	1	74	8.19493709058e-05	0.000421760391198044	JAK2
346	Azotemia	C0242528	1	75	8.41879855894e-05	0.00042298288508557457	GH1
347	Desmoplastic spindle and epithelioid cell melanocytic nevus of skin	C1511789	1	75	8.41879855894e-05	0.0004242053789731051	GHR
348	Eating disorder	C0013473	1	75	8.41879855894e-05	0.00042542787286063574	GH1
349	Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement	C2939461	1	76	8.64565359677e-05	0.0004266503667481663	JAK2
350	Small face	C1855538	1	76	8.64565359677e-05	0.0004278728606356968	GHR
351	Short toe	C1836195	1	77	8.87551324519e-05	0.0004290953545232274	GHR
352	Intestinal obstruction	C0021843	1	78	9.10836201841e-05	0.00043031784841075793	JAK2
353	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	3	1700	9.17317517798e-05	0.0004315403422982885	GHR,GH2,GH1
354	Severe combined immunodeficiency due to ADA deficiency	C0085110	2	545	9.29134009973e-05	0.0004327628361858191	JAK2,GHR
355	Abnormal thrombosis	C4025731	1	79	9.34421360332e-05	0.00043398533007334963	JAK2
356	Abnormality of multiple cell lineages in the bone marrow	C0000772	1	79	9.34421360332e-05	0.0004352078239608802	JAK2
357	Benign melanocytic nevus	C1456781	1	80	9.58305881138e-05	0.00043643031784841075	GH1
358	Xenograft Model	C1520166	2	551	9.59874838797e-05	0.00043765281173594134	JAK2,GH1
359	Multiple Endocrine Neoplasia Type 1	C0025267	1	81	9.82489665294e-05	0.00043887530562347187	GH1
360	Chromosome Aberrations	C0008625	1	81	9.82489665294e-05	0.0004400977995110024	JAK2
361	Uveomeningoencephalitic Syndrome	C0042170	1	81	9.82489665294e-05	0.00044132029339853304	JAK2
362	Vestibular dysfunction	C1843865	1	82	0.000100697322698	0.0004425427872860636	JAK2
363	Hydatidiform mole, recurrent, 2	C0020217	1	82	0.000100697322698	0.00044376528117359416	GH1
364	Immunodeficiency due to defect in CD3-gamma	C0021051	2	571	0.000106717212203	0.0004449877750611247	JAK2,PTPN1
365	Chronic active hepatitis	C0520463	1	86	0.000110790016491	0.00044621026894865523	GH1
366	Polyphagia	C0020505	1	86	0.000110790016491	0.0004474327628361858	GH1
367	Liver regeneration disorder	C1318485	1	87	0.000113387913013	0.0004486552567237164	PTPN1
368	Microdontia	C0240340	1	87	0.000113387913013	0.000449877750611247	GHR
369	Abnormality of the coronary arteries	C0158623	1	88	0.000116015767404	0.0004511002444987775	JAK2
370	Thyroid adenoma	C0151468	1	89	0.000118673516191	0.00045232273838630805	GH1
371	Abnormality of the face	C4025871	3	1817	0.00011927848375	0.00045354523227383864	JAK2,GHR,GH1
372	Actinic keratosis	C0022602	1	91	0.000124078639679	0.00045476772616136917	GHR
373	DNA Damage	C0012860	1	91	0.000124078639679	0.00045599022004889976	JAK2
374	Sepsis	C0243026	2	602	0.000124862374475	0.00045721271393643035	JAK2,GHR
375	Sporadic	C0205422	1	92	0.000126826028174	0.0004584352078239609	JAK2
376	Depressed nasal ridge	C1842876	1	92	0.000126826028174	0.00045965770171149146	GHR
377	Prion Diseases	C0162534	1	93	0.000129603306894	0.000460880195599022	GH1
378	Parathyroid adenoma	C0262587	1	93	0.000129603306894	0.0004621026894865526	JAK2
379	Abnormality of pulmonary circulation	C4280730	1	93	0.000129603306894	0.0004633251833740831	JAK2
380	Elevated pulmonary artery pressure	C3805917	1	93	0.000129603306894	0.0004645476772616137	JAK2
381	Breast carcinoma	C0678222	4	4281	0.000130444835206	0.0004657701711491443	JAK2,GHR,PTPN1,GH1
382	body mass	C0518010	1	94	0.000132410384991	0.0004669926650366748	PTPN1
383	Bruising susceptibility	C0009938	1	94	0.000132410384991	0.0004682151589242054	JAK2
384	Arterial thrombosis	C0151942	1	94	0.000132410384991	0.00046943765281173594	JAK2
385	Kidney Failure, Chronic	C0022661	2	616	0.000133681541314	0.0004706601466992665	PTPN1,GH1
386	Creutzfeldt-Jakob Syndrome	C0022336	1	95	0.000135247311973	0.00047188264058679706	GH1
387	Prolactinoma, familial	C0033375	1	95	0.000135247311973	0.00047310513447432765	GH1
388	Failure to thrive	C0015544	2	622	0.000137583223058	0.00047432762836185823	GHR,GH1
389	Endotoxemia	C0376618	1	96	0.000138114107668	0.00047555012224938877	GHR
390	Peripheral Arterial Diseases	C1704436	1	96	0.000138114107668	0.0004767726161369193	JAK2
391	Polyglandular autoimmune syndrome, type 1	C0085409	1	96	0.000138114107668	0.0004779951100244499	JAK2
392	Biliary Atresia	C0005411	1	96	0.000138114107668	0.0004792176039119804	GHR
393	Testicular malignant germ cell tumor	C0855197	1	96	0.000138114107668	0.00048044009779951106	GH2
394	Paresthesia	C0030554	1	97	0.000141010767067	0.0004816625916870416	JAK2
395	Aplasia/Hypoplasia of toe	C3551148	1	98	0.000143937192546	0.0004828850855745721	GHR
396	Rigidity	C0026837	1	99	0.000146893464762	0.0004841075794621027	GH1
397	Leukemia, B-Cell	C2004493	1	100	0.000149879548078	0.00048533007334963324	JAK2
398	Delayed eruption of teeth	C0239174	1	100	0.000149879548078	0.00048655256723716383	GHR
399	Prematurely aged appearance	C1857656	1	100	0.000149879548078	0.00048777506112469436	GHR
400	Scoliosis	C0036439	2	641	0.000150431538732	0.0004889975550122249	GHR,GH1
401	Osteoporosis	C0029456	2	642	0.000151128760842	0.0004902200488997555	GHR,GH1
402	Abnormal vascular physiology	C4022603	1	101	0.000152895432593	0.0004914425427872861	JAK2
403	Abnormality of cerebral artery	C4021520	1	101	0.000152895432593	0.0004926650366748167	JAK2
404	Neoplasms	C0027651	2	646	0.000153938968957	0.0004938875305623472	JAK2,GH1
405	Myelofibrosis	C0026987	1	102	0.000155941141984	0.0004951100244498778	JAK2
406	Schizophrenia	C0036341	3	1947	0.000156612973239	0.0004963325183374083	GHR,PTPN1,GH1
407	B-cell lymphoma	C0079731	2	652	0.000158218409514	0.0004975550122249388	JAK2,PTPN1
408	Calcinosis	C0006663	1	103	0.000159016637787	0.0004987775061124695	JAK2
409	Abnormality of the skeletal system	C4021790	3	1961	0.000161094843053	0.0005	JAK2,GHR,GH1
410	Hyperhidrosis	C0020458	1	104	0.000162121941414	0.0005012224938875307	JAK2
411	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	3	1967	0.000163044355062	0.0005024449877750611	JAK2,PTPN1,GH1
412	Leukemogenesis	C0598766	2	660	0.000164044983515	0.0005036674816625917	JAK2,PTPN1
413	Hereditary factor VIII deficiency disease	C0019069	1	105	0.00016525701843	0.0005048899755501222	GH1
414	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	C0266464	1	105	0.00016525701843	0.0005061124694376528	GH1
415	Acute megakaryocytic leukemia	C0023462	1	106	0.000168421829747	0.0005073349633251833	JAK2
416	Thrombocytosis, benign familial microcytic	C0836924	1	106	0.000168421829747	0.000508557457212714	JAK2
417	Anterior hypopituitarism	C0302476	1	107	0.000171616426477	0.0005097799511002446	GH1
418	Abnormality of the head	C4021812	3	1995	0.000172374703298	0.000511002444987775	JAK2,GHR,GH1
419	Breast-ovarian cancer, familial 1	C0006142	4	4543	0.000175579185259	0.0005122249388753057	JAK2,GHR,PTPN1,GH1
420	Glomerulosclerosis, Focal Segmental	C0178664	1	109	0.000178094886098	0.0005134474327628362	GH1
421	Delayed menarche	C0232939	1	109	0.000178094886098	0.0005146699266503667	GHR
422	Mandibular prognathia	C0399526	1	109	0.000178094886098	0.0005158924205378973	GHR
423	Colitis, Ulcerative	C0009319	2	679	0.000178444591748	0.0005171149144254279	JAK2,GH1
424	Helicobacter Infections	C0079487	1	110	0.000181378736096	0.0005183374083129584	PTPN1
425	Abnormality of head or neck	C0854297	3	2021	0.000181387629172	0.000519559902200489	JAK2,GHR,GH1
426	Retinal detachment	C0035305	1	111	0.000184692339629	0.0005207823960880196	JAK2
427	Deep venous thrombosis	C0149871	1	112	0.000188035690253	0.0005220048899755501	JAK2
428	Portal hypertension, noncirrhotic	C0020541	1	112	0.000188035690253	0.0005232273838630807	JAK2
429	Adrenal insufficiency	C0001623	1	114	0.000194811485096	0.0005244498777506113	GH1
430	Chronic myelomonocytic leukemia	C0023480	1	115	0.000198243889381	0.0005256723716381418	JAK2
431	Peritonitis	C0031154	1	115	0.000198243889381	0.0005268948655256724	JAK2
432	{Gastric cancer risk after H. pylori infection}, 137215 (3)	C0024623	3	2073	0.000200455521535	0.0005281173594132029	JAK2,GHR,PTPN1
433	Juvenile myelomonocytic leukemia	C0349639	1	116	0.000201706091646	0.0005293398533007335	JAK2
434	Hereditary hyperhomocysteinemia	C0598608	1	116	0.000201706091646	0.000530562347188264	JAK2
435	Diabetes Mellitus, Type 1	C0011849	3	2081	0.000203515695153	0.0005317848410757946	GHR,PTPN1,GH1
436	Generalized abnormality of skin	C4021157	2	712	0.000205384302719	0.0005330073349633253	JAK2,GHR
437	Thromboembolism	C0040038	1	118	0.000208719533423	0.0005342298288508558	JAK2
438	Stomach cancer	C0699791	3	2109	0.000214499327808	0.0005354523227383863	JAK2,GHR,PTPN1
439	Precocious puberty	C0034013	1	120	0.000215851661875	0.0005366748166259169	GH1
440	High forehead	C0239676	1	121	0.000219462245512	0.0005378973105134475	GHR
441	Focal segmental glomerulosclerosis	C0017668	1	121	0.000219462245512	0.0005391198044009779	JAK2
442	Ependymoma	C0014474	1	121	0.000219462245512	0.0005403422982885086	JAK2
443	Abnormality of dental eruption	C1859363	1	122	0.000223102445523	0.0005415647921760392	GHR
444	Thrombophilia	C0398623	1	125	0.000234201013208	0.0005427872860635696	JAK2
445	Impotence	C0242350	1	126	0.000237959814689	0.0005440097799511003	GH1
446	Classical Hodgkin's Lymphoma	C1333064	1	126	0.000237959814689	0.0005452322738386308	JAK2
447	Pancreatic Neoplasms	C0030297	2	750	0.000239561677374	0.0005464547677261614	JAK2,GH1
448	Coronary heart disease 7	C0010054	2	754	0.000243362080693	0.0005476772616136919	JAK2,PTPN1
449	Kidney Diseases	C0022658	2	755	0.000244318347857	0.0005488997555012225	GHR,GH1
450	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	C0031117	2	756	0.000245277072431	0.0005501222493887531	JAK2,GHR
451	Amyloidosis	C0002726	1	129	0.000249413960793	0.0005513447432762836	GH1
452	Elevated hepatic transaminases	C1848701	1	130	0.00025329121776	0.0005525672371638142	JAK2
453	Abnormality of the gingiva	C4021816	1	130	0.00025329121776	0.0005537897310513447	JAK2
454	Hypopituitarism	C0020635	1	131	0.000257198018206	0.0005550122249388753	GH1
455	Pregnancy Complications	C0032962	1	132	0.000261134471607	0.0005562347188264059	JAK2
456	Abnormality of the pulmonary vasculature	C4025271	1	133	0.000265100453208	0.0005574572127139364	JAK2
457	Biliary cirrhosis	C0023892	1	133	0.000265100453208	0.0005586797066014671	JAK2
458	Pulmonary Embolism	C0034065	1	133	0.000265100453208	0.0005599022004889975	JAK2
459	Gastrointestinal hemorrhage	C0017181	1	133	0.000265100453208	0.0005611246943765281	JAK2
460	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	C1853242	1	134	0.000269096071749	0.0005623471882640587	GHR
461	Rett syndrome, congenital variant	C0035372	1	134	0.000269096071749	0.0005635696821515892	PTPN1
462	Abnormalities of the peripheral arteries	C4025247	1	135	0.000273121232315	0.0005647921760391199	JAK2
463	Acute hepatic failure	C0162557	1	135	0.000273121232315	0.0005660146699266504	JAK2
464	Motor Neuron Disease	C0085084	1	136	0.000277175983898	0.0005672371638141809	GH1
465	Pruritus	C0033774	1	138	0.000285374092498	0.0005684596577017115	JAK2
466	Testicular Neoplasms	C0039590	1	139	0.000289517461053	0.0005696821515892421	GH1
467	Jaundice	C0022346	1	141	0.000297892760922	0.0005709046454767726	JAK2
468	Disorder characterized by eosinophilia	C1636667	1	141	0.000297892760922	0.0005721271393643032	JAK2
469	Arterial stenosis	C0038449	1	142	0.000302124675394	0.0005733496332518338	JAK2
470	Venous thrombosis	C0042487	1	142	0.000302124675394	0.0005745721271393643	JAK2
471	Hyperplasia	C0020507	1	143	0.000306386157243	0.0005757946210268949	GH1
472	Eosinophilic disorder	C1306759	1	143	0.000306386157243	0.0005770171149144254	JAK2
473	Hematological Disease	C0018939	1	143	0.000306386157243	0.000578239608801956	JAK2
474	Neoplasm of the colon	C0009375	2	817	0.000308532111061	0.0005794621026894865	JAK2,PTPN1
475	Chronic liver disease	C0341439	1	144	0.000310677114732	0.0005806845965770171	JAK2
476	Neoplastic Cell Transformation	C0007621	1	144	0.000310677114732	0.0005819070904645477	JAK2
477	Chronic myeloid leukemia	C0023473	2	822	0.00031414435414	0.0005831295843520783	JAK2,PTPN1
478	Short long bone	C1854912	1	145	0.000314997536248	0.0005843520782396088	GHR
479	Arthralgia	C0003862	1	149	0.000332574252004	0.0005855745721271393	JAK2
480	Barrett Esophagus	C0004763	1	150	0.000337042062532	0.00058679706601467	GHR
481	Essential thrombocythemia	C0040028	1	150	0.000337042062532	0.0005880195599022005	JAK2
482	Abnormality of the elbow	C4021386	1	150	0.000337042062532	0.000589242053789731	GHR
483	Peripheral Arterial Disease	C0085096	1	151	0.000341539321156	0.0005904645476772617	JAK2
484	Sezary Syndrome	C0036920	1	151	0.000341539321156	0.0005916870415647921	JAK2
485	Visual field defect	C3887875	1	151	0.000341539321156	0.0005929095354523228	JAK2
486	Melanoma	C0025202	3	2386	0.000348258636059	0.0005941320293398533	JAK2,GHR,GH1
487	Congenital Myotonic Dystrophy	C0410226	1	153	0.000350622272732	0.0005953545232273839	GH1
488	Thalassemia	C0039730	1	154	0.00035520786146	0.0005965770171149145	GH1
489	Familial cancer of breast	C0346153	1	155	0.000359822954162	0.000597799511002445	JAK2
490	Dermatological manifestations of systemic disorders	C4025812	1	156	0.000364467431134	0.0005990220048899756	JAK2
491	Chronic obstructive pulmonary disease	C0024117	2	865	0.00036519188469	0.000600244498777506	GHR,PTPN1
492	Autism 15	C0004352	2	868	0.000368942782576	0.0006014669926650367	GHR,GH1
493	Insulinoma	C0021670	1	157	0.000369141253093	0.0006026894865525672	GH1
494	Abnormality of the nasal dorsum	C4021202	1	157	0.000369141253093	0.0006039119804400978	GHR
495	Decreased liver function	C0232744	1	157	0.000369141253093	0.0006051344743276284	JAK2
496	Thrombosis	C0040053	1	157	0.000369141253093	0.0006063569682151589	JAK2
497	Abnormality of the endocrine system	C4025823	2	878	0.000381627642084	0.0006075794621026896	GHR,GH1
498	Psoriasis	C0033860	2	878	0.000381627642084	0.00060880195599022	JAK2,GH1
499	Steinert myotonic dystrophy syndrome	C0027126	1	160	0.000383339349176	0.0006100244498777506	GH1
500	Abnormality of the menstrual cycle	C4025888	1	163	0.000397801858401	0.0006112469437652813	GHR
501	Albuminuria	C0001925	1	163	0.000397801858401	0.0006124694376528117	PTPN1
502	Subcutaneous hemorrhage	C0854107	1	164	0.000402681430971	0.0006136919315403423	JAK2
503	Myeloproliferative disorder (2)	C1292778	1	165	0.000407590321188	0.0006149144254278729	JAK2
504	Abnormality of body height	C4025901	2	908	0.000421386477805	0.0006161369193154034	GHR,GH1
505	Hematopoietic Neoplasms	C0376544	1	168	0.000422493193379	0.0006173594132029339	JAK2
506	Abnormality of the nervous system	C0497552	3	2512	0.000426090606936	0.0006185819070904646	JAK2,GHR,GH1
507	Cachexia	C0006625	1	171	0.000437660042853	0.0006198044009779952	GH1
508	Uterine Cervical Neoplasms	C0007873	1	171	0.000437660042853	0.0006210268948655256	GHR
509	Reduced number of teeth	C4024202	1	172	0.000442774230709	0.0006222493887530563	GHR
510	Abnormality of lipid metabolism	C4025650	1	172	0.000442774230709	0.0006234718826405868	GHR
511	Internal hemorrhage	C0333285	1	174	0.000453090612476	0.0006246943765281174	JAK2
512	Nevus	C0497388	1	174	0.000453090612476	0.0006259168704156479	GH1
513	Eosinophilia	C0014457	1	175	0.000458292731957	0.0006271393643031785	JAK2
514	Bleeding disorder, platelet-type, 21	C0005779	1	177	0.000468784803565	0.0006283618581907091	JAK2
515	Hyperalgesia	C0020429	1	177	0.000468784803565	0.0006295843520782396	JAK2
516	Abnormality of extrapyramidal motor function	C0234133	1	177	0.000468784803565	0.0006308068459657702	GH1
517	Abnormality of skin adnexa morphology	C4023518	2	942	0.000469612953864	0.0006320293398533008	JAK2,GHR
518	Synovial sarcoma	C0039101	1	178	0.000474074704587	0.0006332518337408313	PTPN1
519	Trisomy	C0041107	1	179	0.000479393933421	0.0006344743276283618	JAK2
520	Primary Myelofibrosis	C0001815	1	179	0.000479393933421	0.0006356968215158925	JAK2
521	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	C0013336	2	949	0.000479969213281	0.000636919315403423	GHR,GH1
522	Menstrual irregularities	C0156404	1	180	0.000484742413418	0.0006381418092909535	GHR
523	Abnormality of the cerebral vasculature	C4022001	1	180	0.000484742413418	0.0006393643031784842	JAK2
524	Abnormality of the anterior pituitary	C4023206	1	181	0.000490120033529	0.0006405867970660146	GH1
525	Familial hypercholesterolemia	C0020445	1	182	0.000495527004877	0.0006418092909535452	GHR
526	Abnormality of bone marrow cell morphology	C4021634	1	183	0.000500963154351	0.0006430317848410759	JAK2
527	Hypogonadotropic hypogonadism 7 with or without anosmia	C0022735	1	183	0.000500963154351	0.0006442542787286064	GH1
528	Melanocytic nevus	C0027962	1	185	0.000511923097641	0.000645476772616137	GH1
529	Sensory neuropathy	C0151313	1	185	0.000511923097641	0.0006466992665036675	JAK2
530	Abnormality of body weight	C4025357	2	970	0.000511930491403	0.0006479217603911981	JAK2,GHR
531	Delayed puberty	C0034012	1	186	0.000517446963561	0.0006491442542787285	GHR
532	Hypersensitivity	C0020517	1	186	0.000517446963561	0.0006503667481662592	JAK2
533	Chronic Kidney Insufficiency	C0403447	1	186	0.000517446963561	0.0006515892420537898	GH1
534	Abdominal pain	C0000737	1	187	0.000522999973125	0.0006528117359413202	JAK2
535	Crohn Disease	C0010346	2	979	0.000526042649011	0.0006540342298288509	JAK2,GH1
536	Abnormal number of teeth	C1290508	1	188	0.000528582122854	0.0006552567237163814	GHR
537	Abnormality of oral mucosa	C4023170	1	188	0.000528582122854	0.0006564792176039121	JAK2
538	Abnormality of blood circulation	C4023585	1	189	0.000534193546464	0.0006577017114914425	JAK2
539	Inflammatory Bowel Diseases	C0021390	2	985	0.000535590472691	0.0006589242053789731	JAK2,GH1
540	Polycythemia vera	C0032463	1	192	0.000551202815214	0.0006601466992665038	JAK2
541	Cycloid psychosis	C0349204	1	192	0.000551202815214	0.0006613691931540342	GHR
542	X-Linked mental retardation 90	C1136249	1	195	0.000568474506485	0.0006625916870415648	GH1
543	Acute Erythroblastic Leukemia	C0023440	1	195	0.000568474506485	0.0006638141809290954	JAK2
544	Myocardial Reperfusion Injury	C0027055	1	196	0.00057429000691	0.0006650366748166259	JAK2
545	Developmental delay with short stature, dysmorphic features, and sparse hair	C0424605	1	197	0.000580134721433	0.0006662591687041564	GH1
546	Myocardial Infarction	C0027051	2	1019	0.00059183608245	0.0006674816625916871	JAK2,GH1
547	Abnormality of the nose	C0265736	2	1028	0.000607342754687	0.0006687041564792176	JAK2,GHR
548	Cardiovascular Diseases	C0007222	2	1029	0.00060908190738	0.0006699266503667481	GHR,GH1
549	Arthritis, Rheumatoid	C0003864	2	1030	0.000610824270573	0.0006711491442542788	JAK2,GH1
550	Headache	C0018681	1	204	0.000621862411766	0.0006723716381418093	JAK2
551	Transient ischemic attack	C0007787	1	205	0.000627939932271	0.0006735941320293398	JAK2
552	Mammary Neoplasms, Experimental	C0024668	1	207	0.000640182031585	0.0006748166259168705	GH1
553	Neoplasm, Residual	C0242596	1	208	0.000646346677943	0.000676039119804401	JAK2
554	Dyspnea	C0013404	1	209	0.000652540421618	0.0006772616136919315	JAK2
555	Burkitt lymphoma	C0006413	1	210	0.000658763164345	0.0006784841075794621	GH1
556	Bronchiolitis, Viral	C0006274	1	211	0.000665014928785	0.0006797066014669927	JAK2
557	Pulmonary Emphysema	C0034067	1	211	0.000665014928785	0.0006809290953545231	PTPN1
558	Abnormal platelet count	C0580317	1	212	0.000671295792266	0.0006821515892420538	JAK2
559	Hypercholesterolemia, autosomal dominant, type B	C0020443	1	212	0.000671295792266	0.0006833740831295844	GHR
560	Ataxia-telangiectasia syndrome	C0004135	1	212	0.000671295792266	0.000684596577017115	GH1
